766 
Nicox S.A. (NYSE Euronext Paris: COX) has announced it has established a new Scientific Advisory Board (SAB) with international Key Opinions Leaders (KOLs) in the ophthalmology field. The first SAB meeting will be held on November 14, 2013 in New Orleans, Louisiana, US, with the objective of evaluating the existing data on second generation nitric oxide (NO)-donors and discussing their potential therapeutic use in certain ophthalmic disorders.
Nicox’s SAB will be led by Dr. Richard L. Lindstrom, founder and attending surgeon at Minnesota Eye Consultants and Adjunct Clinical Professor Emeritus at the University of Minnesota Department of Ophthalmology. Dr. Lindstrom is an internationally recognised leader in corneal, cataract, refractive and laser surgery.
AAO 2013
Nicox will attend the 2013 Annual Meeting of the American Academy of Ophthalmology (AAO), taking place from November 16 to 18, 2013 in New Orleans, Louisiana, United States. Nicox can be found at booth number 4719. Nicox’s US and European operational teams will attend the meeting, as well as several members from the Executive team.
About Dr. Richard L. Lindstrom
Dr Richard L. Lindstrom is Founder and attending surgeon at Minnesota Eye Consultants, Adjunct Clinical Professor Emeritus at the University of Minnesota Department of Ophthalmology. He serves as Associate Director at the Minnesota Lions Eye Bank and as Board Member at the University of Minnesota Foundation. He is also Visiting Professor at UC Irvine’s Gavin Herbert Eye Institute and he serves on the Board of Directors of several publicly traded and private companies and on a number of Journal editorial boards.
Dr Lindstrom is a board-certified ophthalmologist and internationally recognised leader in corneal, cataract, refractive and laser surgery. He has been at the forefront of ophthalmology’s evolutionary changes throughout his career, as a recognised researcher, teacher, inventor, writer, lecturer and highly acclaimed physician and surgeon. He holds over 38 patents in ophthalmology and has developed a number of solutions, intraocular lenses and instruments that are used in clinical practices globally.
